Cannara Biotech Inc. (LOVE.TO) stock: key figures, P/E, revenue and dividend
Health Care · Canada
Cannara Biotech Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 81.75 m CAD | 107.32 m CAD |
| Gross profit | 29.79 m CAD | 47.22 m CAD |
| Operating income | 10.08 m CAD | 22.20 m CAD |
| EBIT | 8.81 m CAD | 21.77 m CAD |
| Net income | 6.44 m CAD | 13.08 m CAD |
| Diluted EPS – continuing operations | 0.07 CAD | 0.14 CAD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cannara Biotech Inc.
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
More stocks
- Definitive Healthcare Corp. (DH)
- INSAN Inc. (277410.KQ)
- Yuhwa Securities Co Ltd (003465.KS)
- Kwan's International Co., Ltd. (6101.TWO)
- Win Win Precision Technology Co., Ltd. (4949.TW)
- TPG Mortgage Investment Trust, Inc. (MITT)
- Sinew Pharma Inc. (6634.TWO)
- Taiwan Takisawa Technology Co Ltd (6609.TWO)
- SeA Mechanics Co. Ltd. (396300.KQ)
- Mineralbrunnen Ueberkingen-Teinach GmbH & Co KgaA (MUT.F)
- Freelance.Com (ALFRE.PA)
- Sorento Capital Berhad (0326.KL)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.